Understanding Corticosteroid Potency
Corticosteroids are hormonal medications with potent anti-inflammatory, immunosuppressive, and anti-allergic properties. However, individual agents differ dramatically in strength—some require 20 mg doses while others work at 0.75 mg. Potency describes the relative anti-inflammatory effect compared to a reference standard, typically hydrocortisone.
Each corticosteroid also has a distinct duration of action, ranging from 8–12 hours for short-acting agents like hydrocortisone to 36–54 hours for long-acting drugs like dexamethasone. When converting between medications, clinicians must account for both potency and half-life to avoid under- or over-dosing.
Conversion is straightforward: express the current dose in hydrocortisone-equivalent units, then divide by the potency of the target drug. The resulting dose maintains comparable anti-inflammatory effect, though administration frequency may need adjustment based on duration of action.
Corticosteroid Equivalency Conversion
To convert from one corticosteroid to another, first normalise the current dose to hydrocortisone units, then apply the target drug's potency ratio. The formula for any conversion is:
Equivalent Hydrocortisone Dose = Current Dose × Current Drug Potency
New Steroid Dose = Equivalent Hydrocortisone Dose ÷ New Drug Potency
Hydrocortisone potency reference— Set at 1.0; all other steroids are expressed as multiples or fractionsCortisone— Potency 0.8 (cortisone = hydrocortisone × 1.25)Prednisone & Prednisolone— Potency 4.0 (each = hydrocortisone × 0.25)Triamcinolone & Methylprednisolone— Potency 5.0 (each = hydrocortisone × 0.2)Dexamethasone— Potency 30 (dexamethasone = hydrocortisone × 0.0375)Betamethasone— Potency 30 (betamethasone = hydrocortisone × 0.03)
Example: Prednisone to Methylprednisolone Conversion
Consider a patient on 20 mg prednisone daily. To switch to methylprednisolone (Solu-Medrol) while maintaining equivalent anti-inflammatory effect:
Step 1: Convert prednisone to hydrocortisone equivalent: 20 mg prednisone × 4 = 80 mg hydrocortisone-equivalent
Step 2: Convert to methylprednisolone: 80 mg ÷ 5 = 16 mg methylprednisolone
The patient should receive 16 mg of methylprednisolone to achieve the same therapeutic effect. However, since methylprednisolone lasts 12–36 hours versus prednisone's 12–36 hours, the administration schedule may remain unchanged. For longer-acting agents like dexamethasone (36–54 hours), dosing frequency should decrease accordingly.
Duration of Action and Dosing Intervals
Corticosteroids fall into three categories by half-life: short-acting (hydrocortisone, cortisone: 8–12 hours), intermediate (prednisone, prednisolone, triamcinolone, methylprednisolone: 12–36 hours), and long-acting (dexamethasone, betamethasone: 36–54 hours).
When converting between agents, adjust the dosing frequency to match the new drug's duration. A patient on hydrocortisone 20 mg three times daily (60 mg/day total, short-acting) might convert to prednisone 15 mg once daily (intermediate-acting), not three divided doses. Similarly, 100 mg cortisone (short-acting) equals only 3 mg dexamethasone (long-acting), which may last multiple days.
Failure to adjust dosing intervals can result in subtherapeutic troughs or toxic peaks. Always consult the prescribing information and institutional guidelines for the specific agent.
Practical Considerations for Steroid Conversion
These key points help prevent dosing errors and adverse outcomes during corticosteroid switches.
- Verify potency ratios from current guidelines — Anti-inflammatory potency can vary slightly between sources. Cross-reference this calculator's values with current clinical guidelines or your institution's formulary before finalising a prescription. Potency ratios are standardised by most national regulators but may be updated.
- Account for bioavailability differences — These conversions assume equivalent oral or IV absorption. Intramuscular, topical, or inhaled corticosteroids have different bioavailability and should not be converted using this method. Always check whether the patient's current and proposed routes of administration are the same.
- Adjust dosing frequency based on half-life — Converting from a short-acting to a long-acting steroid without reducing frequency risks accumulation and toxicity. Moving from long-acting to short-acting without increasing frequency may result in therapeutic failure. Consult pharmacokinetic data for the specific agent.
- Monitor clinical response after conversion — Equivalent potency does not guarantee identical clinical effect in every patient. Individual factors—comorbidities, drug interactions, weight, renal/hepatic function—influence efficacy. Plan follow-up assessments within days to 1–2 weeks of switching to confirm therapeutic adequacy.